Literature DB >> 28498588

The clinical relevance of appraisals of psychotic experiences.

Philippa A Garety1,2, Amy Hardy1.   

Abstract

Entities:  

Year:  2017        PMID： 28498588      PMCID： PMC5428177          DOI： 10.1002/wps.20408

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  9 in total

1.  A cognitive model of the positive symptoms of psychosis.

Authors:  P A Garety; E Kuipers; D Fowler; D Freeman; P E Bebbington
Journal:  Psychol Med       Date:  2001-02       Impact factor: 7.723

2.  Therapeutic advances for people with delusions will come from greater specification and empirical investigation.

Authors:  Philippa Garety
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 3.  Sowing the seeds of doubt: a narrative review on metacognitive training in schizophrenia.

Authors:  Steffen Moritz; Christina Andreou; Brooke C Schneider; Charlotte E Wittekind; Mahesh Menon; Ryan P Balzan; Todd S Woodward
Journal:  Clin Psychol Rev       Date:  2014-05-06

4.  The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: a meta-analysis.

Authors:  Mark van der Gaag; Lucia R Valmaggia; Filip Smit
Journal:  Schizophr Res       Date:  2014-04-14       Impact factor: 4.939

Review 5.  An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders.

Authors:  R J Linscott; J van Os
Journal:  Psychol Med       Date:  2012-07-31       Impact factor: 7.723

6.  Dopamine and the aberrant salience hypothesis of schizophrenia.

Authors:  Oliver D Howes; Matthew M Nour
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

Review 7.  The past and future of delusions research: from the inexplicable to the treatable.

Authors:  P A Garety; D Freeman
Journal:  Br J Psychiatry       Date:  2013-11       Impact factor: 9.319

8.  Clinical, socio-demographic and psychological characteristics in individuals with persistent psychotic experiences with and without a "need for care".

Authors:  Emmanuelle Peters; Thomas Ward; Mike Jackson; Craig Morgan; Monica Charalambides; Philip McGuire; Peter Woodruff; Pamela Jacobsen; Paul Chadwick; Philippa A Garety
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

9.  Cognitive mechanisms of change in delusions: an experimental investigation targeting reasoning to effect change in paranoia.

Authors:  Philippa Garety; Helen Waller; Richard Emsley; Suzanne Jolley; Elizabeth Kuipers; Paul Bebbington; Graham Dunn; David Fowler; Amy Hardy; Daniel Freeman
Journal:  Schizophr Bull       Date:  2014-07-21       Impact factor: 9.306
  9 in total
  4 in total

1.  Clinical relevance of appraisals of persistent psychotic experiences in people with and without a need for care: an experimental study.

Authors:  Emmanuelle Peters; Thomas Ward; Mike Jackson; Peter Woodruff; Craig Morgan; Philip McGuire; Philippa A Garety
Journal:  Lancet Psychiatry       Date:  2017-12       Impact factor: 27.083

2.  Pathways from Trauma to Psychotic Experiences: A Theoretically Informed Model of Posttraumatic Stress in Psychosis.

Authors:  Amy Hardy
Journal:  Front Psychol       Date:  2017-05-23

3.  SlowMo, a digital therapy targeting reasoning in paranoia, versus treatment as usual in the treatment of people who fear harm from others: study protocol for a randomised controlled trial.

Authors:  Philippa A Garety; Thomas Ward; Daniel Freeman; David Fowler; Richard Emsley; Graham Dunn; Elizabeth Kuipers; Paul Bebbington; Helen Waller; Kathryn Greenwood; Mar Rus-Calafell; Alison McGourty; Amy Hardy
Journal:  Trials       Date:  2017-11-02       Impact factor: 2.279

Review 4.  Fast and slow thinking in distressing delusions: A review of the literature and implications for targeted therapy.

Authors:  Thomas Ward; Philippa A Garety
Journal:  Schizophr Res       Date:  2017-09-18       Impact factor: 4.939
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.